Nasdaq Combined Compos (COMPX.US)

Close: 17 383.00 (+216.90), Apr 25, 2025
Weak Positive

Low risk

Automatic technical analysis. Short term, Apr 25, 2025

Nasdaq Combined Composite Index has broken the ceiling of the falling trend in the short term, which indicates a slower initial falling rate. The index has marginally broken up through resistance at points 17300. An established break predicts a further rise. The index is assessed as technically slightly positive for the short term.

Recommendation one to six weeks: Weak Positive (Score: 29)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.98%0.00+1.26%
5 days0.003.26%0.00+6.73%
22 days0.008.04%0.00-4.86%
66 days0.0015.63%0.00-12.02%

More analyses of Nasdaq Combined Composite Index

chart Nasdaq Combined Composite Index (COMPX) Candlesticks 22 Days
Candlesticks
chart Nasdaq Combined Composite Index (COMPX) Short term
Short term: Weak Positive
chart Nasdaq Combined Composite Index (COMPX) Medium term
Medium term: Weak Positive
chart Nasdaq Combined Composite Index (COMPX) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.